Giessen, Germany

Ivo Zunke

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Berkenhoff Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ivo Zunke. Retrieved from https://idiyas.com/inventor/ivo-zunke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ivo Zunke: Innovator at Berkenhoff GmbH

Introduction

Ivo Zunke is a notable inventor based in Gie en, Germany. He is currently associated with Berkenhoff GmbH, where he contributes to various innovative projects. Despite having no patents to his name, his work in the field of innovation is recognized by his peers.

Latest Patents

Ivo Zunke currently holds 1 patents. This indicates that he may be in the early stages of his inventive career or focusing on collaborative projects rather than individual patent filings.

Career Highlights

Throughout his career, Ivo has been involved in several significant projects at Berkenhoff GmbH. His role has allowed him to work on cutting-edge technologies and contribute to the company's growth and innovation strategies.

Collaborations

Ivo collaborates closely with his coworker, Stefan Flügge. Their partnership is essential in driving forward the innovative initiatives at Berkenhoff GmbH.

Conclusion

Ivo Zunke is an emerging inventor whose contributions at Berkenhoff GmbH highlight his potential in the field of innovation. His collaborative efforts and dedication to his work are commendable, and he is poised for future achievements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…